Phibro Animal Health
PAHC
153 hedge funds and large institutions have $441M invested in Phibro Animal Health in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 75 increasing their positions, 48 reducing their positions, and 22 closing their positions.
56% more repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 48
2.14% less ownership
Funds ownership: 103.95% → 101.81% (-2.1%)
9% less funds holding
Funds holding: 168 → 153 (-15)
34% less capital invested
Capital invested by funds: $670M → $441M (-$229M)
64% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 22
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $4K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$14.7M |
| 2 |
CSC
Cove Street Capital
El Segundo,
California
|
+$9.98M |
| 3 |
Janus Henderson Group
London,
|
+$7.79M |
| 4 |
TAM
Tocqueville Asset Management
New York
|
+$5.88M |
| 5 |
Millennium Management
New York
|
+$4.09M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CVA
Ceredex Value Advisors
Orlando,
Florida
|
-$17.5M |
| 2 |
FMI
Fiduciary Management Inc
Milwaukee,
Wisconsin
|
-$10.9M |
| 3 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
-$9.14M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$5.96M |
| 5 |
Fuller & Thaler Asset Management
San Mateo,
California
|
-$5.93M |
PAHC Hedge Fund Activity: Q3 2019 in Review
153 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q3 2019, worth a combined $441M — down 34% from $670M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of PAHC and 8 opened new positions — a net loss of 14 holders — while 48 trimmed existing stakes and 75 added.
The largest buyer was Morgan Stanley, adding an estimated $14.7M. The largest seller was Ceredex Value Advisors, cutting an estimated $17.5M.
- 153 institutional investors held Phibro Animal Health (PAHC) as of Q3 2019, down from 168 in Q2 2019.
- Funds reported $441M of Phibro Animal Health stock for Q3 2019, down 34% quarter-over-quarter.
- 8 funds opened new Phibro Animal Health positions in Q3 2019 and 22 closed out, a net change of -14 holders.
- The largest Phibro Animal Health buyer in Q3 2019 was Morgan Stanley, an estimated $14.7M added.
- The largest Phibro Animal Health seller in Q3 2019 was Ceredex Value Advisors, an estimated $17.5M sold.
Based on aggregated 13F filings for Q3 2019.